Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., et al. (2003). Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology, 28(2), 235-243.